Feature Nanobiotix pioneering nanomedicine in new paradigm against cancer By Len Zehrs France’s Nanobiotix (Euronext:NANO) is hoping to change the paradigm for cancer treatment with a single nanomedicine applicable across oncology for millions of patients. “What differentiates us is that we... May 15, 2018